"Low-to-moderate arsenic exposure: a global systematic review of cardiovascular disease risks"
- PMID: 40346670
- PMCID: PMC12065288
- DOI: 10.1186/s12940-025-01184-5
"Low-to-moderate arsenic exposure: a global systematic review of cardiovascular disease risks"
Abstract
High arsenic (As) exposure (≥ 100 µg/l) is associated with cardiovascular (CVD) outcomes, however, the CVD risk from low-to-moderate As exposure (< 100 µg/l) has been less explored. There is a paucity of systematic reviews that comprehensively evaluate both urine and water As exposure metrics in assessing As-related CVD outcomes within the general population. To fill this gap, this review sought to update and consolidate data regarding the correlation between low-to-moderate As exposure and specific CVD outcomes, including stroke, ischemic heart disease (IHD), acute myocardial infarction (AMI), and heart failure (HF). A search for peer-reviewed articles indexed in PubMed, Embase, CINAHL, the Global Medicos Index, and Web of Science and unpublished dissertations in Prospero until October 31, 2024, was performed. Nineteen studies were included. Relative risks were pooled by contrasting the highest v/s lowest exposure groups across studies. Positive associations were observed between urine As and stroke incidence, and water As with IHD incidence. Associations between water As and IHD and AMI mortality were suggestive and became stronger after excluding ecological studies. Sex-stratified analyses suggested an increased risk for all groups with strongest indication of an increased risk of AMI mortality in men. Increased risk was suggested for HF but only two studies assessed this outcome. These findings underscore potential risk for CVD outcomes in relation to low-to-moderate As exposure, and highlight the necessity for additional rigorous, well-structured studies to more clearly delineate the possible effects of low-to-moderate As exposure on different CVD outcomes.
Keywords: Acute Myocardial Infarction; Arsenic; Cardiovascular disease; Heart Failure; Ischemic Heart Disease; Stroke.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: Not applicable. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Figures
Similar articles
-
Mortality and Morbidity Effects of Long-Term Exposure to Low-Level PM2.5, BC, NO2, and O3: An Analysis of European Cohorts in the ELAPSE Project.Res Rep Health Eff Inst. 2021 Sep;2021(208):1-127. Res Rep Health Eff Inst. 2021. PMID: 36106702 Free PMC article.
-
A prospective study of arsenic exposure, arsenic methylation capacity, and risk of cardiovascular disease in Bangladesh.Environ Health Perspect. 2013 Jul;121(7):832-8. doi: 10.1289/ehp.1205797. Epub 2013 May 10. Environ Health Perspect. 2013. PMID: 23665672 Free PMC article.
-
Long-Term Exposure to Arsenic in Community Water Supplies and Risk of Cardiovascular Disease among Women in the California Teachers Study.Environ Health Perspect. 2024 Oct;132(10):107006. doi: 10.1289/EHP14410. Epub 2024 Oct 23. Environ Health Perspect. 2024. PMID: 39440943 Free PMC article.
-
Aspirin Use in Adults: Cancer, All-Cause Mortality, and Harms: A Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2015 Sep. Report No.: 13-05193-EF-1. Rockville (MD): Agency for Healthcare Research and Quality (US); 2015 Sep. Report No.: 13-05193-EF-1. PMID: 26491756 Free Books & Documents. Review.
-
Ambient air pollution and cardiovascular diseases: An umbrella review of systematic reviews and meta-analyses.J Intern Med. 2022 Jun;291(6):779-800. doi: 10.1111/joim.13467. Epub 2022 Mar 8. J Intern Med. 2022. PMID: 35138681 Free PMC article.
References
-
- Chen QY, Costa M. Arsenic: a global environmental challenge. Annu Rev Pharmacol Toxicol. 2021;61:47–63. 10.1146/annurev-pharmtox-030220-013418. - PubMed
-
- Balakumar P, Kaur J. Arsenic exposure and cardiovascular disorders: an overview. Cardiovasc Toxicol. 2009;9(4):169–76. 10.1007/s12012-009-9050-6. - PubMed
-
- Moreira Freire B, Neves Lange C, Pedron T, Lemos Batista B. Chapter two - arsenic in environment: historic, concepts, occurrence and problems. In: Singh VP, Tripathi DK, Fotopoulos V, Lemos Batista B, Tortella Fuentes G, Da Silva Lobato AK, editors. The role of gasotransmitters in the amelioration of arsenic toxicity in plants. Academic Press; 2023. p. 19–36. 10.1016/B978-0-323-98800-1.00004-6.
-
- Nriagu JO. Arsenic poisoning through the ages. Environ Chem Arsen. 2002;1:1–26.
-
- Chen Y, Parvez F, Gamble M, et al. Arsenic exposure at low-to-moderate levels and skin lesions, arsenic metabolism, neurological functions, and biomarkers for respiratory and cardiovascular diseases: review of recent findings from the Health Effects of Arsenic Longitudinal Study (HEALS) in Bangladesh. Toxicol Appl Pharmacol. 2009;239(2):184–92. 10.1016/j.taap.2009.01.010. - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous